Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 13 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
Sanofi (NASDAQ:SNY) Shares Acquired by Putnam Investments LLC
ETF DAILY NEWS· 2 days agoPutnam Investments LLC boosted its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,342,709 ...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoSanofi, which records sales of Dupixent, reported $11.6 billion in sales last year. This year, sales...
Exploring Three Top Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 1 day agoIn recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index...
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
InvestorPlace· 7 days agoIn a meme frenzy, any positive news related to a company has a magnified impact on the stock price....
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 3 days agoPrice Performance Over the past year, Charles River shares have risen 4.4% compared with the...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 4 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Goldman Sachs raises Royalty Pharma stock target on deal activity By Investing.com
Investing.com· 7 days agoOn Friday, Goldman Sachs (NYSE:GS) updated its financial model for Royalty Pharma (NASDAQ:RPRX),...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 7 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...